Opening Session - Discussion

Conference on Liver Disease in Africa (COLDA) 2020

Management of HBV - Test & Treat Strategy - Hailemichael Desalegn

Conference on Liver Disease in Africa (COLDA) 2020

Inclusion of Vulnerable Groups in HCV Prevention, Testing, and Treatment in the African Region - Niklas Luhmann

Conference on Liver Disease in Africa (COLDA) 2020

Résistance du VHB aux Inhibiteurs Nucléo(s)tidiques de la Transcriptase Inverse (INTI) et son Impact sur l’Aantigène de Surface (AgHBs) chez des Patients Co-Infectés VHB-VIH à Abidjan - Leto Olivier Gogbe

Conference on Liver Disease in Africa (COLDA) 2020

Access to Treatment in Africa - Oriel Fernandes

Conference on Liver Disease in Africa (COLDA) 2020

Management of HBV in Children - Manal El-Sayed

Conference on Liver Disease in Africa (COLDA) 2020

Current Advances in HBV Cure Research - Massimo Levrero (French)

Conference on Liver Disease in Africa (COLDA) 2020

Current Advances in HBV Cure Research - Massimo Levrero (English)

Conference on Liver Disease in Africa (COLDA) 2020

DNA Methyltransferases as Potential Biomarkers of HCV Related Hepatocellular Carcinoma - Mona Hassouna

Conference on Liver Disease in Africa (COLDA) 2020

Hepatocellular Carcinoma in Senegal: Epidemiological, Clinical and Etiological Aspects about 229 Cases at Hopital Principal de Dakar - Ibrahima Diallo (French)

Conference on Liver Disease in Africa (COLDA) 2020

Hepatocellular Carcinoma in Senegal: Epidemiological, Clinical and Etiological Aspects about 229 Cases at Hopital Principal de Dakar - Ibrahima Diallo (English)

Conference on Liver Disease in Africa (COLDA) 2020

Propranolol Reduces Portal Vein Diameter in Schistosomal Liver Disease with Portal Hypertension: a Prospective Cohort Study - Edford Sinkala

Conference on Liver Disease in Africa (COLDA) 2020

Seroprevalence and Molecular Epidemiology of Hepatitis C in Malawi: A Cross-Sectional Community Census-Based Serological Survey of Ndriande, Blantyre - Alexander Stockdale

Conference on Liver Disease in Africa (COLDA) 2020

Hépatite Virale C Chronique: Efficacité et Tolérance des Antiviraux à Action Directe au Centre Hospitalier Universitaire Yalgado Ouédraogo - Jamila Abdouramane Soli

Conference on Liver Disease in Africa (COLDA) 2020

Prevalence of Occult Hepatitis C Virus Infection among Egyptian Haemodialysis Patients: A Single Centre Study - Tari George Michael

Conference on Liver Disease in Africa (COLDA) 2020

NAFLD/NASH Policies and Practice in Sub-Saharan Africa - Jeffrey Lazarus

Conference on Liver Disease in Africa (COLDA) 2020

Diabetes, Obesity, and COVID-19 - Joel Dave

Conference on Liver Disease in Africa (COLDA) 2020

Fat and the Liver in the African Population - Ponsiano Ocama

Conference on Liver Disease in Africa (COLDA) 2020

Particularities of HCC in Africa - Lewis Roberts

Conference on Liver Disease in Africa (COLDA) 2020

Impact of COVID-19 on the Existing Elimination Programs - John Ward

Conference on Liver Disease in Africa (COLDA) 2020

Community Experience while Delivering Hepatitis B Services during the Pandemic - Arafat Bwambale

Conference on Liver Disease in Africa (COLDA) 2020

Hepatitis B Awareness and Perceptions Among Healthcare Workers Across Africa: R1eport From the African Hepatitis B Network - Jose Debes

Conference on Liver Disease in Africa (COLDA) 2020

Frequency of Occult Hepatitis B Virus among Blood Donors in Khartoum State, Sudan: a Preliminary Study - Mustafa Yassin

Conference on Liver Disease in Africa (COLDA) 2020

Experience of the First Hepatitis B Program in Rural Sierra Leone: One Year of Successes and Challenges - Marta Maria Patino Rodriguez

Conference on Liver Disease in Africa (COLDA) 2020